Page 93 - Read Online
P. 93
efficient to use than BMSCs. These characteristics, CONCLUSION
coupled with the observation that there is no significant
difference between ASCs and BMSCs in facilitating Sensory and motor regeneration are major hurdles that
nerve regeneration, points to ASCs as being a more must be addressed to realize the fullest potential of VCA.
efficient option in stem cell‑based enhancement of nerve Advances continue to be made in peripheral nerve repair, and
regeneration. [65] these results must be explored in the context of transplant
surgery. Results in post‑VCA functional outcomes continue to
While the transplantation of Schwann cells into nerve improve, and soon, we can expect more consistent, reliable,
conduits has demonstrated increased regenerative and faster recovery of sensation and motor control to donor
[66]
potential, ASCs have also been demonstrated to have tissues. Exciting advancements in the area of ASC‑enhanced
a pro‑regenerative effect on growing axons. [67‑70] The nerve regeneration may offer a promising frontier towards
mechanism for this effect is in the differentiation of ASCs addressing this challenging question.
into Schwann cell‑like phenotypes in the context of nerve
injury and regeneration. Interestingly, undifferentiated REFERENCES
[71]
ASCs (uASCs) can also promote nerve growth.
In vitro differentiation of uASCs into Schwann cells prior 1. Chim H, Amer H, Mardini S, Moran SL. Vascularized composite allotransplant
to seeding demonstrated no significant difference as in the realm of regenerative plastic surgery. Mayo Clin Proc 2014;89:1009‑20.
compared to uASCs in the graft‑guided regeneration 2. Fischer S, Lian CG, Kueckelhaus M, Strom TB, Edelman ER, Clark RA,
of a ten millimeter injury of rat sciatic nerve. Similar Murphy GF, Chandraker AK, Riella LV, Tullius SG, Pomahac B. Acute
[72]
rejection in vascularized composite allotransplantation. Curr Opin Organ
findings were demonstrated in facial nerve repair with Transplant 2014;19:531‑44.
uASC/differentiated ASC seeding of the graft. A large 3. Oliveira JT, Bittencourt‑Navarrete RE, de Almeida FM, Tonda‑Turo C,
[68]
meta‑analysis published in July 2014 examining data from Martinez AM, Franca JG. Enhancement of median nerve regeneration by
mesenchymal stem cells engraftment in an absorbable conduit: improvement
forty‑four animal studies revealed that the use of ASCs of peripheral nerve morphology with enlargement of somatosensory cortical
in nerve grafts offers significant benefits toward nerve representation. Front Neuroanat 2014;8:111.
regeneration in sciatic, median, ulnar, and radial nerve 4. Scheib J, Höke A. Advances in peripheral nerve regeneration. Nat Rev Neurol
lesion models in rats, dogs, monkeys, and mice. [73] 5. 2013;9:668‑76.
Raff MC, Whitmore AV, Finn JT. Axonal self‑destruction and
The regenerative benefits of ASCs require their seeding 6. neurodegeneration. Science 2002;296:868‑71.
Glaus SW, Johnson PJ, Mackinnon SE. Clinical strategies to enhance
along the path of the growing axon sprouts, as well as nerve regeneration in composite tissue allotransplantation. Hand Clin
being in an environment that maintains the population 2011;27:495‑509, ix.
for the weeks to months required for axonal regrowth. 7. Oyamatsu H, Koga D, Igarashi M, Shibata M, Ushiki T. Morphological
Existing Food and Drug Administration‑approved nerve assessment of early axonal regeneration in end‑to‑side nerve coaptation
models. J Plast Surg Hand Surg 2012;46:299‑307.
conduits with specialized matrices for ASC maintenance 8. Pomahac B, Pribaz J. Facial composite tissue allograft. J Craniofac Surg
adequately meets these requirements, thereby creating 2012;23:265‑7.
a microenvironment in which such stem cells can 9. Lykissas MG. Current concepts in end‑to‑side neurorrhaphy. World J Orthop
2011;2:102‑6.
readily affect pro‑regenerative signals on growing axons 10. Audolfsson T, Rodríguez‑Lorenzo A, Wong C, Cheng A, Kildal M, Nowinski D,
in a spatially constrained path. ASCs are capable of Rozen S. Nerve transfers for facial transplantation: a cadaveric study for
secreting nerve growth factors, vascular endothelial motor and sensory restoration. Plast Reconstr Surg 2013;131:1231‑40.
growth factor, and brain‑derived neurotrophic factor, 11. Rinker B, Vyas KS. Clinical applications of autografts, conduits, and allografts
in repair of nerve defects in the hand: current guidelines. Clin Plast Surg
among a wider set of cytokines and other cell signaling 2014;41:533‑50.
molecules. The strength of a cellular graft over one that 12. Rivlin M, Sheikh E, Isaac R, Beredjiklian PK. The role of nerve allografts and
[71]
merely elutes neurotrophic factors is that the molecular conduits for nerve injuries. Hand Clin 2010;26:435‑46, viii.
microenvironment can be regulated by ASCs in response 13. Moore AM, Kasukurthi R, Magill CK, Farhadi HF, Borschel GH, Mackinnon SE.
Limitations of conduits in peripheral nerve repairs. Hand (N Y) 2009;4:180‑6.
to the penetrating sprouts. [74] 14. Mackinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome
following nerve allograft transplantation. Plast Reconstr Surg 2001;107:1419‑29.
ASCs prove to be a promising area of research for the 15. Midha R, Mackinnon SE, Becker LE. The fate of Schwann cells in peripheral
facilitation of nerve regeneration in VCA. Early in vivo nerve allografts. J Neuropathol Exp Neurol 1994;53:316‑22.
research demonstrating seeding of these cells into 16. Elkwood AI, Holland NR, Arbes SM, Rose MI, Kaufman MR, Ashinoff RL,
artificial conduits and grafts has provided promising Parikh MA, Patel TR. Nerve allograft transplantation for functional restoration
of the upper extremity: case series. J Spinal Cord Med 2011;34:241‑7.
results. However, these remain restricted to animal 17. Gold BG. FK506 and the role of immunophilins in nerve regeneration.
models of the peripheral nerve lesion. The combined Mol Neurobiol 1997;15:285‑306.
promise of beneficial immunomodulatory effects and 18. Toll EC, Seifalian AM, Birchall MA. The role of immunophilin ligands in nerve
regeneration. Regen Med 2011;6:635‑52.
enhanced nerve regeneration makes these cells a 19. Jensen JN, Brenner MJ, Tung TH, Hunter DA, Mackinnon SE. Effect of
tantalizing therapeutic supplementation in VCA. The FK506 on peripheral nerve regeneration through long grafts in inbred swine.
extent of these benefits as a clinical application in VCA Ann Plast Surg 2005;54:420‑7.
remains to be studied. 20. Landin L, Cavadas PC, Gonzalez E, Rodriguez JC, Caballero A. Functional
outcome after facial allograft transplantation in rats. J Plast Reconstr Aesthet Surg
A summary of recent and pertinent publications 2008;61:1034‑43.
regarding ASCs in VCA/nerve regeneration can be found 21. Song Y, Wang Z, Wang Z, Zhang H, Li X, Chen B. Use of FK506 and bone
marrow mesenchymal stem cells for rat hind limb allografts. Neural Regen Res
in Table 4. 2012;7:2681‑8.
Plast Aesthet Res || Vol 2 || Issue 4 || Jul 15, 2015 233